Veterinary Diagnostics Market Size Worth USD 13.0 Billion, Globally, by 2033 at a CAGR of 6.97% Billion

Market Overview:

According to IMARC Group's latest research publication, "Veterinary Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033" The global veterinary diagnostics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of Veterinary Diagnostics Market

• AI is analyzing medical images like X-rays to detect abnormalities, which helps veterinarians make faster and more accurate diagnoses.
• AI-powered sensors in wearables are monitoring animal vitals, which provides early warnings of health issues and allows for proactive care.
• AI is being used to analyze patient data, which helps to predict disease outcomes and create more personalized treatment plans. AI-driven lab analyzers are automating sample analysis, which helps to reduce human error and increase the efficiency of veterinary clinics.
• AI-enabled mobile apps are offering preliminary health assessments, which helps pet owners to decide whether a vet visit is necessary.

Grab a sample PDF of this report: https://www.imarcgroup.com/veterinary-diagnostics-market/requestsample

Key Trends in the Veterinary Diagnostics Market

• Shift to point-of-care (POC) testing: The market is seeing a major trend toward on-site diagnostics. Veterinarians are increasingly using portable and user-friendly devices in their clinics to get fast results. This allows for immediate treatment decisions, which is critical for urgent cases and improves client satisfaction.
• Growing demand for molecular diagnostics: There's a strong trend toward more accurate and sensitive testing methods. Molecular diagnostics, like PCR, are being used to detect pathogens at the genetic level, even in asymptomatic animals. This technology offers a significant leap in precision and helps to combat the spread of infectious diseases.
• Focus on companion animal diagnostics: The market is trending toward pet care. With an estimated 66% of U.S. households owning a pet, there's a huge demand for advanced care. This humanization of pets is driving pet owners to invest more in preventive diagnostics and sophisticated tests.
• Development of multi-pathogen screening panels: A key trend is the ability to test for multiple diseases at once. These new panels can simultaneously screen for numerous pathogens from a single sample. This is not only more efficient but also vital for surveillance programs aimed at identifying potential zoonotic outbreaks early.
• Integration of diagnostic tools into a "One Health" approach: The market is trending toward a holistic view of health. Diagnostics are no longer just for animal care; they are now considered a critical part of public health. This is driven by the need to monitor and control diseases that can jump between animals and humans.

Growth Factors in the Veterinary Diagnostics Market

• Rising pet ownership and spending on animal health: A primary growth factor is the increasing number of people with pets. As pet owners see their animals as family members, they are more willing to spend on their care, with an average American owner spending over $140 on their dog per month, which drives demand for diagnostic services.
• Growing prevalence of zoonotic and chronic diseases: A major catalyst is the increase in diseases that affect animals. Zoonotic diseases, like avian influenza, and chronic conditions are becoming more common, which is creating a continuous and urgent need for diagnostics to ensure timely and accurate diagnosis and treatment.
• Technological advancements and product innovations: The market is being fueled by new technology. Innovations like faster immunodiagnostics, improved imaging modalities, and high-throughput molecular testing are making it easier and more efficient for veterinarians to diagnose a wide range of conditions.
• Favorable government initiatives and policies: A significant growth factor is government support for animal health. In India, for instance, schemes are helping to modernize veterinary infrastructure and control livestock diseases, which is boosting the overall market for diagnostics and encouraging the development of new solutions.
• Expansion of veterinary reference laboratories: The market is being driven by the growth of specialized labs. These labs offer a wider range of tests, advanced technology, and expertise, which supports the increasing need for complex diagnostics and helps veterinary clinics to provide a higher standard of care.

Ask analyst of customized report: https://www.imarcgroup.com/request?type=report&id=2739&flag=E

Leading Companies Operating in the Global Veterinary Diagnostics Industry:

• BioChek B.V.
• Biomérieux SA
• Heska Corporation
• IDvet
• IDEXX Laboratories Inc.
• Neogen Corporation
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Virbac
• Zoetis Inc.

Veterinary Diagnostics Market Report Segmentation:

By Product:

• Instruments
• Kits and Reagents
• Software and Services

Kits and reagents exhibit a clear dominance in the market attributed to their widespread use in a variety of tests, offering quick, reliable results for numerous animal diseases.

By Technology:

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Others

Clinical biochemistry represents the largest segment, as it provides essential information on the metabolic and physiological status of animals.

By Animal Type:

• Companion Animals
• Dogs
• Cats
• Others
• Livestock Animals
• Cattle
• Swine
• Poultry
• Others

Livestock animals hold the biggest market share accredited to the rising need for disease prevention and efficient production in livestock farming to ensure food security and economic stability.

By Disease Type:

• Infectious Diseases
• Non-infectious Diseases
• Hereditary, Congenital and Acquired Diseases
• General Ailments
• Structural and Functional Diseases

Non-infectious diseases account for the majority of the market share, driven by the growing concern over chronic conditions and genetic disorders in animals that impact longevity and quality of life.

By End User:

• Reference Laboratories
• Veterinary Hospitals and Clinics
• Others

Reference laboratories represent the largest segment due to their advanced diagnostic capabilities, comprehensive test offerings, and the expertise to handle a wide range of samples from various animal species.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market owing to the existence of robust animal healthcare infrastructure, the increasing number of pet parents, and the rising investment in animal health research and development (R&D).

Recent News and Developments in Veterinary Diagnostics Market

• October 2024: Zoetis launched Vetscan Imagyst, a new platform using AI for urine sediment analysis to help veterinarians diagnose conditions like UTIs. This innovation marks a significant step in expanding the capabilities of in-clinic diagnostic tools and leveraging AI for quicker, more accurate results.
• May 2025: A key development is a new collaboration between Texas A&M and the University of Georgia on zoonotic diseases. This partnership focuses on using advanced diagnostics to combat infectious diseases, like Chagas, in dogs, which highlights the growing importance of the "One Health" approach.
• July 2024: A notable development is a new partnership between a leading diagnostic company and a major university to accelerate research on a new technology for rapid, point-of-care testing for companion animals. The new technology promises to provide highly accurate results in just minutes, which will help to transform veterinary care.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302